StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Total area of facilities under operational control by Year

Total area of facilities under operational control (M sq. ft.)

Gilead Sciences Total area of facilities under operational control: 9 in FY2025, up 0.6% from a year earlier.

Latest, FY2025
9
Period ended Dec 31, 2025
Change on a year earlier
+0.6%
9 in FY2024
History
7 years
Since FY2019
Sources
2
Documents cited below

Where the FY2025 figure comes from

“Total Area of Facilities Under Operational Control 7.31M 8.63M 8.54M 8.59M”

Source: Gilead Sustainability / IR (environmental-sustainability-data-performance-tables.pdf) ↗

Reported in Gilead Environmental Sustainability Data Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Gilead Sciences Total area of facilities under operational control, annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/esg-floor-area

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.